Clinical and cost implications of amyloid beta detection with amyloid beta positron emission tomography imaging in early Alzheimer’s disease – the case of florbetapir-Reference-Cited by-同舟云学术

Clinical and cost implications of amyloid beta detection with amyloid beta positron emission tomography imaging in early Alzheimer’s disease – the case of florbetapir

Published:2017-01-24 Issue:4 Volume:33 Page:675-685
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Hornberger John¹²,Bae Jay³,Watson Ian³,Johnston Joe³,Happich Michael⁴

Affiliation:

1. Cedar Associates, Menlo Park, CA USA;

2. Stanford University, Stanford, CA USA;

3. Eli Lilly and Company, Indianapolis, IN USA;

4. Eli Lilly and Company, Bad Homburg, Germany

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2016.1277197

Reference78 articles.

1. Dementia syndromes: evaluation and treatment

2. Alzheimer’s and Dementia in France. Chicago, IL. Available at: http://www.alz.org/fr/dementia-alzheimers-france.asp [Last accessed 19 December 2016]

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Scottish Intercollegiate Guidelines Network Guidance on Dementia: The Investigation of Suspected Dementia (SIGN 168) with Focus on Biomarkers—Executive Summary;Thrombosis and Haemostasis;2024-05-24

2. Leveraging Technology to Diagnose Alzheimer’s Disease: A Systematic Review and Meta-Analysis;Healthcare;2023-11-21

3. Retinal optical coherence tomography biomarkers in dementia;Die Ophthalmologie;2023-10-17

4. Optical coherence tomography findings in children of patients with Alzheimer-type dementia;The Egyptian Journal of Neurology, Psychiatry and Neurosurgery;2023-07-13

5. Charting the Next Road Map for CSF Biomarkers in Alzheimer's Disease and Related Dementias;Neurotherapeutics;2023-07